866-997-4948(US-Canada Toll Free)

Japan Neuromodulation Devices Market Outlook to 2025

Published By :

GlobalData

Published Date : Nov 2018

Category :

Medical Equipments

No. of Pages : 35 Pages

Japan Neuromodulation Devices Market Outlook to 2025

Summary

GlobalDatas new report, Japan Neuromodulation Devices Market Outlook to 2025, provides key market data on the Japan Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Neuromodulation Devices market.
- Global corporate-level profiles of key companies operating within the Japan Neuromodulation Devices market.
- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Neuromodulation Devices Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Neuromodulation Devices Market, Japan 6
3.1 Neuromodulation Devices Market, Japan, Revenue ($m), 2015-2025 6
3.2 Neuromodulation Devices Market, Japan, Volume (Units), 2015-2025 9
3.3 Neuromodulation Devices Market, Japan, Average Price ($), 2015-2025 12
3.4 Neuromodulation Devices Market, Japan, Distribution Share by Revenue ($m), 2017 14
3.5 Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2017 15
4 Overview of Key Companies in Japan, Neuromodulation Devices Market 17
4.1 Boston Scientific Corp 17
4.1.1 Company Overview 17
4.2 Medtronic Plc 17
4.2.1 Company Overview 17
4.3 Nevro Corp 17
4.3.1 Company Overview 17
4.4 LivaNova PLC 17
4.4.1 Company Overview 17
4.5 Abbott Laboratories 18
4.5.1 Company Overview 18
5 Neuromodulation Devices Market Pipeline Products 19
6 Financial Deals Landscape 23
6.1 Asset Transactions 23
6.1.1 Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 23
7 Recent Developments 25
7.1 Corporate Communications 25
7.1.1 Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director 25
7.1.2 Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice 25
7.2 Financial Announcements 25
7.2.1 May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018 25
7.3 Legal And Regulatory 28
7.3.1 Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified 28
7.4 Strategy And Business Planning 28
7.4.1 Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya 28
8 Appendix 29
8.1 Research Methodology 30
8.1.1 Coverage 30
8.1.2 Secondary Research 30
8.1.3 Primary Research 31
8.1.4 Market Modeling and Forecasting 32
8.1.5 Company Share Analysis 33
8.1.6 Distribution Share Analysis 34
8.1.7 Benchmarking 34
8.2 GlobalData Consulting 34
8.3 Contact Us 35
8.4 Disclaimer 35

1.1 List of Tables
Table 1: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2015-2020 7
Table 2: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2021-2025 8
Table 3: Neuromodulation Devices Market, Japan, Volume (Units), 2015-2020 10
Table 4: Neuromodulation Devices Market, Japan, Volume (Units), 2021-2025 11
Table 5: Neuromodulation Devices Market, Japan, Average Price ($), 2015-2020 12
Table 6: Neuromodulation Devices Market, Japan, Average Price ($), 2021-2025 13
Table 7: Neuromodulation Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017 14
Table 8: Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2017 16
Table 9: Neuromodulation Devices Market Pipeline Products 19
Table 10: Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 23
Table 11: Total Number of Primary Research Participants, Neurology Devices Market, by Country 32

1.2 List of Figures
Figure 1: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2015-2025 6
Figure 2: Neuromodulation Devices Market, Japan, Volume (Units), 2015-2025 9
Figure 3: Neuromodulation Devices Market, Japan, Company Share (%) 2017 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *